Nicole Beaton Sur

Nicole Beaton Sur

Auto-generated profile, based on publicly available information

Nicole Beaton Sur

Department of Neurology, University of Miami, FL (N.B.S.).

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
FOFadar Oliver Otite
Fadar Oliver Otite
VSVasu Saini
Vasu Saini
NSNicole Beaton Sur
Nicole Beaton Sur
SPSmit Patel
Smit Patel
RSRicha Sharma
Richa Sharma
SCSeemant Chaturvedi
Seemant Chaturvedi
Background and Purpose: IV tPA (intravenous thrombolysis with alteplase) and mechanical thrombectomy (MT) utilization increased in acute ischemic stroke hospitalizations in the United States over the last decade. It is uncertain whether this increase occurred equally across all age, sex, and racial groups. Methods: Adult acute ischemic stroke hospitalizations (weighted n=4 442 657) contained in the 2008 to 2017 National Inpatient Sample were identified using International Classification of Diseases codes. Proportions of hospitalizations with IV tPA and MT were computed according to age, sex, and race. Joinpoint and multivariable-adjusted logistic regression models were used to evaluate trends over time. Results: Across this period, 32.4% of all hospitalizations were in patients ≥80 years, and 64.7% of these were women. IV tPA and MT use differed by age with highest proportion of utilization of both treatments in patients aged 18 to 39 years (IV tPA, 12.3%) and lowest percentage in patients aged ≥90 years (IV tPA, 7.9%). Utilization of both procedures increased over time in all age groups, but the pace of increase was faster in patients ≥90 years compared with patients aged 18 to 39 years (MT: odds ratio, 1.25 [95% CI, 1.20–1.35] per unit increase in year, P interaction 10% in all demographic subgroups except in Black patients 60 to 79 years and Black patients ≥80 years. Analysis of race-by-time interaction revealed the Black-vs-White treatment gaps for IV tPA (odds ratio, 1.02 [95% CI, 1.01–1.03]) and MT (odds ratio, 1.08 [95% CI,1.05–1.12]) declined over time (both P interaction <0.01). Sex-related differences in IV tPA use were noted, but this gap also declined over time. Conclusions: Age- and sex-related treatment gaps in IV tPA and MT reduced over the last decade. Racial disparity in IV tPA and MT utilization persists with particularly lower frequency of usage of both acute stroke treatments in Black patients compared with White patients, but race-associated treatment gaps also declined over time.

1 June 2019 in Stroke
Verified
Journal Article
Closed access
PDF file
NSNicole B. Sur
Nicole B. Sur
KWKefeng Wang
Kefeng Wang
MTMarco R. Di Tullio
Marco R. Di Tullio
CGCarolina M. Gutierrez
Carolina M. Gutierrez
CDChuanhui Dong
Chuanhui Dong
Tatjana RundekTatjana Rundek
Tatjana Rundek
Background and Purpose—: Ischemic stroke (IS) secondary to atrial fibrillation (AF) is largely preventable with the use of anticoagulation. We sought to identify race-ethnicity and sex disparities with the use of direct oral anticoagulants (DOACs), aspirin, and warfarin in IS patients with AF and to identify temporal trends in the utilization of these medications. Methods—: The FLiPER-AF Stroke Study (Florida Puerto Rico Atrial Fibrillation) included 24 040 IS cases enrolled in the Florida-Puerto Rico Collaboration to Reduce Stroke Registry from 2010 to 2016. Multivariable logistic regression models were performed to evaluate the effect of race-ethnicity and sex on utilization of DOACs, aspirin, and warfarin for stroke prevention in AF after adjustment for sociodemographic, hospital, and clinical factors. Results—: Among 24 040 IS cases, 54% were women and 10% black, 12% FL-Hispanics, 4% PR-Hispanic, and 74% whites. From 2010 to 2016, DOAC use increased from 0% to 36%, warfarin use decreased from 51% to 17%, and aspirin use remained relatively stable (42%–40%). After adjustment, blacks had higher odds of warfarin (odds ratio, 1.22; 95% CI, 1.07–1.40) prescription at discharge compared with whites. Men had higher rates of aspirin (42.1% versus 38.8%), warfarin (33.6% versus 28.9%), and DOAC (21.3% versus 19.3%) use compared with women. After adjustment, women had lower odds of being discharged on aspirin (odds ratio, 0.92; 95% CI, 0.86–0.98) or warfarin (odds ratio, 0.91; 95% CI, 0.84–0.99). There was no sex difference in use of DOACs. Conclusions—: Our study confirmed the increasing use of DOACs, downtrending use of warfarin, whereas aspirin use remained similar over the years. There are sex and race-ethnicity disparities in anticoagulation use in IS patients with AF. It is critical to understand underlying drivers of these disparities to develop better practice strategies for stroke prevention in patients with AF. Clinical Trial Registration—: URL: https://www.clinicaltrials.gov . Unique identifier: NCT03627806.

1 March 2023 in Stroke
Verified
Journal Article
Closed access
NANegar Asdaghi
Negar Asdaghi
KWKefeng Wang
Kefeng Wang
HGHannah Gardener
Hannah Gardener
AJAngus Jameson
Angus Jameson
DRDAVID Z ROSE
DAVID Z ROSE
FRFor The Florida Stroke Registry
For The Florida Stroke Registry
Background: The impact of time to treatment on outcomes of endovascular thrombectomy (EVT) especially in patients presenting after 6 hours from symptom onset is not well characterized. We studied the differences in characteristics and treatment timelines of EVT-treated patients participating in the Florida Stroke Registry and aimed to characterize the extent to which time impacts EVT outcomes in the early and late time windows. Methods: Prospectively collected data from Get With the Guidelines–Stroke hospitals participating in the Florida Stroke Registry from January 2010 to April 2020 were reviewed. Participants were EVT patients with onset-to-puncture time (OTP) of ≤24 hours and categorized into early window treated (OTP ≤6 hours) and late window treated (OTP >6 and ≤24 hours). Association between OTP and favorable discharge outcomes (independent ambulation, discharge home and to acute rehabilitation facility) as well as symptomatic intracerebral hemorrhage and in-hospital mortality were examined using multilevel-multivariable analysis with generalized estimating equations. Results: Among 8002 EVT patients (50.9% women; median age [±SD], 71.5 [±14.5] years; 61.7% White, 17.5% Black, and 21% Hispanic), 34.2% were treated in the late time window. Among all EVT patients, 32.4% were discharged home, 23.5% to rehabilitation facility, 33.7% ambulated independently at discharge, 5.1% had symptomatic intracerebral hemorrhage, and 9.2% died. As compared with the early window, treatment in the late window was associated with lower odds of independent ambulation (odds ratio [OR], 0.78 [0.67–0.90]) and discharge home (OR, 0.71 [0.63–0.80]). For every 60-minute increase in OTP, the odds of independent ambulation reduced by 8% (OR, 0.92 [0.87–0.97]; P <0.001) and 1% (OR, 0.99 [0.97–1.02]; P =0.5) and the odds of discharged home reduced by 10% (OR, 0.90 [0.87–0.93]; P <0.001) and 2% (OR, 0.98 [0.97–1.00]; P =0.11) in the early and late windows, respectively. Conclusions: In routine practice, just over one-third of EVT-treated patients independently ambulate at discharge and only half are discharged to home/rehabilitation facility. Increased time from symptom onset to treatment is significantly associated with lower chance of independent ambulation and ability to be discharged home after EVT in the early time window.

1 January 2024 in Stroke
Verified
Journal Article
Closed access
NSNicole B Sur
Nicole B Sur
MKMariel G. Kozberg
Mariel G. Kozberg
PDPatrice Desvigne-Nickens
Patrice Desvigne-Nickens
CSCandice Silversides
Candice Silversides
CBCheryl Bushnell
Cheryl Bushnell
Stroke is a leading cause of death and disability in the United States and worldwide, necessitating comprehensive efforts to optimize stroke risk factor management. Health disparities in stroke incidence, prevalence, and risk factor management persist among various race/ethnic, geographic, and socioeconomic populations and negatively impact stroke outcomes. This review highlights existing literature and guidelines for stroke risk factor management, emphasizing health disparities among certain populations. Moreover, stroke risk factors for special groups, including the young, the very elderly, and pregnant/peripartum women are outlined. Strategies for stroke risk factor improvement at every level of the health care system are discussed, from the individual patient to providers, health care systems, and policymakers. Improving stroke risk factor management in the context of the social determinants of health, and with the goal of eliminating inequities and disparities in stroke prevention strategies, are critical steps to reducing the burden of stroke and equitably improving public health.

1 September 2025 in Stroke
Verified
Journal Article
Closed access
LSLiqi Shu
Liqi Shu
YAYasmin N. Aziz
Yasmin N. Aziz
AHAdam de Havenon
Adam de Havenon
SMSteven R. Messe
Steven R. Messe
Thanh N NguyenThanh N Nguyen
Thanh N Nguyen
SYShadi Yaghi
Shadi Yaghi
Perioperative stroke, defined as a cerebrovascular event occurring during surgery or within 30 days postoperatively, remains a devastating complication associated with substantial morbidity, disability, mortality, and increased healthcare utilization. Although overall incidence is relatively low—up to 1% in most surgical populations—it is significantly elevated in cardiac, major vascular, and neurosurgical procedures, often exceeding 5%. The rising prevalence of perioperative stroke, primarily driven by an aging surgical population burdened by multiple chronic vascular conditions and increasingly eligible for high-risk surgical interventions, underscores the urgency of optimizing preventive and management strategies. This review synthesizes insights into patient- and procedure-related risk factors, highlighting the intricate interplay of embolic, thrombotic, and hypoperfusion mechanisms underpinning perioperative ischemic strokes. Key patient-specific risks include advanced age, recent cerebrovascular events, atrial fibrillation, carotid stenosis, and chronic cardiovascular comorbidities. Procedural factors, such as the type and complexity of surgery, intraoperative hypotension, and vascular manipulations, further modulate stroke risk. Emphasizing an evidence-based approach to risk mitigation, this review examines preoperative risk stratification, intraoperative techniques designed to minimize cerebral embolization and preserve adequate perfusion, and structured postoperative protocols aimed at rapid stroke detection. Acute management complexities are also discussed, with careful consideration of intravenous thrombolysis and mechanical thrombectomy in the postoperative setting. Finally, gaps in current guidelines and promising areas for future research are identified, advocating a multidisciplinary approach involving neurology, surgery, anesthesiology, and allied specialties to enhance patient outcomes and reduce the perioperative stroke burden.

1 November 2020 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
TCThiago Carneiro
Thiago Carneiro
JDJonathan Dashkoff
Jonathan Dashkoff
LLLester Y. Leung
Lester Y. Leung
CNChrista O'HAna S. Nobleza
Christa O'HAna S. Nobleza
EMErika Marulanda-Londono
Erika Marulanda-Londono
ACAnna M. Cervantes-Arslanian
Anna M. Cervantes-Arslanian